Attovia Therapeutics closes IPO, adopts amended charter and bylaws

Attovia Therapeutics, Inc.

IPO closed on August 6, 2026; amended charter and bylaws became effective.
Common stock trades on Nasdaq under ticker ATTO.
Prospectus dated August 4, 2026 describes capital stock provisions.
Company qualifies as an emerging growth company under SEC rules.

item 5.03 item 9.01

Attovia Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-338037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.